Diacylglycerol kinase θ counteracts protein kinase C-mediated inactivation of the EGF receptor
Diacylglycerol kinase θ counteracts protein kinase C-mediated inactivation of the EGF receptor
Epidermal growth factor receptor (EGFR) activation is negatively regulated by protein kinase C (PKC) signaling. Stimulation of A431 cells with EGF, bradykinin or UTP increased EGFR phosphorylation at Thr654 in a PKC-dependent manner. Inhibition of PKC signaling enhanced EGFR activation, as assessed by increased phosphorylation of Tyr845 and Tyr1068 residues of the EGFR. Diacylglycerol is a physiological activator of PKC that can be removed by diacylglycerol kinase (DGK) activity. We found, in A431 and HEK293 cells, that the DGKθ isozyme translocated from the cytosol to the plasma membrane, where it co-localized with the EGFR and subsequently moved into EGFR-containing intracellular vesicles. This translocation was dependent on both activation of EGFR and PKC signaling. Furthermore, DGKθ physically interacted with the EGFR and became tyrosine-phosphorylated upon EGFR stimulation. Overexpression of DGKθ attenuated the bradykinin-stimulated, PKC-mediated EGFR phosphorylation at Thr654, and enhanced the phosphorylation at Tyr845 and Tyr1068. SiRNA-induced DGKθ downregulation enhanced this PKC-mediated Thr654 phosphorylation. Our data indicate that DGKθ translocation and activity is regulated by the concerted activity of EGFR and PKC and that DGKθ attenuates PKC-mediated Thr654 phosphorylation that is linked to desensitisation of EGFR signaling.
Bradykinin/pharmacology, Cell Line, Tumor, Cell Membrane/metabolism, Diacylglycerol Kinase/metabolism, Endosomes/drug effects, Enzyme Activation/drug effects, ErbB Receptors/metabolism, Gene Silencing/drug effects, Green Fluorescent Proteins/metabolism, HEK293 Cells, Humans, Phosphorylation/drug effects, Phosphothreonine/metabolism, Phosphotyrosine/metabolism, Protein Binding/drug effects, Protein Kinase C/metabolism, Protein Transport/drug effects, Tetradecanoylphorbol Acetate/pharmacology, Uridine Triphosphate/pharmacology
1791-1799
van Baal, Jürgen
b6b47118-7a83-41f0-9bf0-c1760380ada7
de Widt, John
8e144c94-ffc7-47c5-afe9-1dc463c3621f
Divecha, Nullin
5c2ad0f8-4ce7-405f-8a15-2fc4ab96d787
van Blitterswijk, Wim J
aa501394-3d66-4738-9483-b025ce31b3c7
November 2012
van Baal, Jürgen
b6b47118-7a83-41f0-9bf0-c1760380ada7
de Widt, John
8e144c94-ffc7-47c5-afe9-1dc463c3621f
Divecha, Nullin
5c2ad0f8-4ce7-405f-8a15-2fc4ab96d787
van Blitterswijk, Wim J
aa501394-3d66-4738-9483-b025ce31b3c7
van Baal, Jürgen, de Widt, John, Divecha, Nullin and van Blitterswijk, Wim J
(2012)
Diacylglycerol kinase θ counteracts protein kinase C-mediated inactivation of the EGF receptor.
The International Journal of Biochemistry & Cell Biology, 44 (11), .
(doi:10.1016/j.biocel.2012.06.021).
Abstract
Epidermal growth factor receptor (EGFR) activation is negatively regulated by protein kinase C (PKC) signaling. Stimulation of A431 cells with EGF, bradykinin or UTP increased EGFR phosphorylation at Thr654 in a PKC-dependent manner. Inhibition of PKC signaling enhanced EGFR activation, as assessed by increased phosphorylation of Tyr845 and Tyr1068 residues of the EGFR. Diacylglycerol is a physiological activator of PKC that can be removed by diacylglycerol kinase (DGK) activity. We found, in A431 and HEK293 cells, that the DGKθ isozyme translocated from the cytosol to the plasma membrane, where it co-localized with the EGFR and subsequently moved into EGFR-containing intracellular vesicles. This translocation was dependent on both activation of EGFR and PKC signaling. Furthermore, DGKθ physically interacted with the EGFR and became tyrosine-phosphorylated upon EGFR stimulation. Overexpression of DGKθ attenuated the bradykinin-stimulated, PKC-mediated EGFR phosphorylation at Thr654, and enhanced the phosphorylation at Tyr845 and Tyr1068. SiRNA-induced DGKθ downregulation enhanced this PKC-mediated Thr654 phosphorylation. Our data indicate that DGKθ translocation and activity is regulated by the concerted activity of EGFR and PKC and that DGKθ attenuates PKC-mediated Thr654 phosphorylation that is linked to desensitisation of EGFR signaling.
This record has no associated files available for download.
More information
Accepted/In Press date: 13 June 2012
e-pub ahead of print date: 22 June 2012
Published date: November 2012
Additional Information:
Copyright © 2012 Elsevier Ltd. All rights reserved.
Keywords:
Bradykinin/pharmacology, Cell Line, Tumor, Cell Membrane/metabolism, Diacylglycerol Kinase/metabolism, Endosomes/drug effects, Enzyme Activation/drug effects, ErbB Receptors/metabolism, Gene Silencing/drug effects, Green Fluorescent Proteins/metabolism, HEK293 Cells, Humans, Phosphorylation/drug effects, Phosphothreonine/metabolism, Phosphotyrosine/metabolism, Protein Binding/drug effects, Protein Kinase C/metabolism, Protein Transport/drug effects, Tetradecanoylphorbol Acetate/pharmacology, Uridine Triphosphate/pharmacology
Identifiers
Local EPrints ID: 479722
URI: http://eprints.soton.ac.uk/id/eprint/479722
ISSN: 1357-2725
PURE UUID: 4bebdaf4-ff04-4a40-98ba-262b6b275859
Catalogue record
Date deposited: 26 Jul 2023 16:54
Last modified: 17 Mar 2024 02:58
Export record
Altmetrics
Contributors
Author:
Jürgen van Baal
Author:
John de Widt
Author:
Wim J van Blitterswijk
Download statistics
Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.
View more statistics